2-(4-Dodecylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Catalog No. :
ACFRNC510
CAS No. :
1398398-12-3
Molecular Formula :
C24H41BO2
Molecular Weight :
372.40

IUPAC Name:2-(4-dodecylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(4-Dodecylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$59.00Login to see priceIn stockInquiry
1g97%$165.00Login to see priceIn stockInquiry
5g97%$657.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Dodecylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
IUPAC Name2-(4-dodecylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Molecular FormulaC24H41BO2
Molecular Weight372.40
SMILESCC(C(C)(C)O1)(C)OB1C2=CC=C(CCCCCCCCCCCC)C=C2
InChI KeyNJBRYWISNRIQIH-UHFFFAOYSA-N
Synonym1,3,2-Dioxaborolane, 2-(4-dodecylphenyl)-4,4,5,5-tetramethyl-;2-(4-Dodecylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
CAS No.1398398-12-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACFRNC510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACHYVQ052 route compound structure diagram
    ACHYVQ052126930-72-1 In Stock
  4. Then
  5. ACFRNC510 route product structure diagram
    ACFRNC5101398398-12-3 In Stock
Inquiry

2. ACFRNC510 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHPYN347 route compound structure diagram
    ACHPYN34768716-49-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFRNC510 route product structure diagram
    ACFRNC5101398398-12-3 In Stock
Inquiry

Comments (0)